MedTrace Logo

Micropulse Laser for Geographic Atrophy

NCT01799564 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2019-09-18

No results posted yet for this study

Summary

Geographic atrophy (GA) causes the loss of the retinal pigment epithelium (RPE) cells in broad areas of the retina. The application of subthreshold micropulse laser spots in healthy RPE in the vicinity of the area of GA may restore the imbalance in survival factors caused by the disease (ie, the laser may decrease vascular endothelial growth factor and RPE-derived transforming growth factor beta, upregulation of pigment epithelium-derived factor). This may slow or even stop the enlargement of atrophy secondary to GA, and therefore, avoid further vision loss.

Conditions

Interventions

PROCEDURE

Micropulse

Between 1 and 3 sessions of micropulse laser will be applied in the inferior hemiretina of the randomly selected eye

Sponsors & Collaborators

  • Institut de la Macula y la Retina

    lead OTHER

Principal Investigators

  • Jordi Monés, MD, PhD · Institut de la màcula i de la retina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-11-27
Completion
2013-11-27

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01799564 on ClinicalTrials.gov